Learn More
Invitrogen™ Human EDEM3 (aa 823-931) Control Fragment Recombinant Protein
Recombinant Protein
Marca: Invitrogen™ RP105774
Descripción
Highest antigen sequence indentity to the following orthologs: Mouse (72%), Rat (72%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-65009 (PA5-65009. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
Involved in endoplasmic reticulum-associated degradation (ERAD). Accelerates the glycoprotein ERAD by proteasomes, by catalyzing mannose trimming from Man8GlcNAc2 to Man7GlcNAc2 in the N-glycans. Seems to have alpha 1,2-mannosidase activity.
Especificaciones
Q9BZQ6 | |
Blocking Assay, Control | |
80267 | |
100 μL | |
2310050N11Rik; Alpha-1,2-mannosidase EDEM3; C1orf22; EDEM3; ER degradation enhancer, mannosidase alpha-like 3; ER degradation enhancing alpha-mannosidase like protein 3; ER degradation-enhancing alpha-mannosidase-like 3; ER degradation-enhancing alpha-mannosidase-like protein 3; ER degradation-enhancing -mannosidase-like protein 3; RGD1561496 | |
EDEM3 | |
Human | |
His-ABP-tag | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
≥5.0 mg/mL | |
1 M urea, PBS with no preservative; pH 7.4 | |
Human EDEM3 (aa 823-931) Control Fragment | |
RUO | |
EDEM3 | |
Unconjugated | |
Recombinant | |
SSQEVDLVDQESSEENSLNSHPESLSLADMDNAASISPSEQTSNPTENHETTNLNGECTDLDNQLQEQSETEEDSNPNVSWGKKVQPIDSILADWNEDIEAFEMMEKDE | |
E. coli | |
>80% by SDS-PAGE and Coomassie blue staining |
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.